Protein technologies

GINYS-CRG-003
Carlo Carolis
Head of Unit
The Biomolecular and Protein Screening Technologies Unit (BMS & PT) offers CRG-CNAG / PRBB researchers, external institutions and private companies a new high-quality technological platform to carry out the production of proteins and automated processes in the context of biomolecular and biochemical screening assays. Through staff-assisted detection, users will have access to facility equipment, including liquid handlers, plate readers, and small molecule libraries. In addition, the unit aims to support CRG institute researchers by purchasing, researching, and maintaining valuable stocks of clones and strains.

Services

  • Full service production of plasmid clones, mutants and plasmid libraries.
  • High performance cloning
  • Production of recombinant proteins and protein complexes: bacteria, insect cells and mammalian expression
  • Purification of proteins and antibodies
  • Biophysical characterization of proteins and nucleic acids:
  • Surface plasmon resonance, microscale thermophoresis, size exclusion chromatography – multiangle light scattering
  • Automation of biomolecular and biochemical screening assays
  • Genome editing using the Crispr-Cas9 system: knockout / Knockin gene cell line engineering in collaboration with the CRG Tissue Engineering Unit

Equipment

  • ÄKTA Xpress twin and ÄktaFPLC system for protein purification (GE Healthcare)
  • Biacore T100 (SPR)
  • Monolith NT.115 Thermophoresis (MST)
  • UPLC (shimatzu) – DAWN8 + Optilab® T-rEX ™
  • LabCHIP GXII
  • TECAN Freedom evo 200 robotic platform
  • Caliper Zephyr robotic platform
  • Caliper Sciclone robotic platform
  • Biotek ELx405 washing machine
  • Kendro incubator
  • MultidropV2
  • Tecan M200 plate reader
  • Electroporator Amaxa 96-inch plate
siRNA libraries

The entire human genome collection siGENOME SMARTPoool, (Dharmacon, Thermo-Fisher) consists of groups of 4 different siRNAs per gene and is distributed in four “sets” as follows

  • Kinases – 779 gens
  • GPCR – 516 people
  • “Drugable” genome: 6022 genes
  • Remaining genome collection: 13803 genes
Chemical compound libraries
  • The Prestwick Chemical Library®: 1200 small molecules, 100% marketed drugs
  • Prestwick Phytochemical Library – 320 natural products
  • Tocris kinase inhibitor toolbox (Tocris): 80 small molecule compounds

Staff

Carlo Carolis | carlo.carolis@crg.eu | ORCID | PRC Page

Projects

Title: ARBRE: The association for resources for biophysical research in Europe
Funding Organism: COST-UE
Status: Executing
Title: EPIC-XS: Proteomics (2019-2022)
Reference: https://epic-xs.eu/
Funding Organism: EU
Status: Executing

Publications

Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts
Carlota Dobaño, Selena Alonso, Marta Vidal, Alfons Jiménez, Rocío Rubio, Rebeca Santano, Diana Barrios, Gemma Pons Tomas, María Melé Casas, María Hernández García, Mònica Girona-Alarcón, Laura Puyol, Natalia Rodrigo Melero, Carlo Carolis, Aleix Garcia-Miquel, Elisenda Bonet-Carne, Joana Claverol, Marta Cubells, Claudia Fortuny, Victoria Fumadó, Anna Codina, Quique Bassat, Carmen Muñoz-Almagro, Mariona Fernández de Sevilla, Eduard Gratacós, Luis Izquierdo, Juan José García-García, Ruth Aguilar, Iolanda Jordan, Gemma Moncunill
Frontiers In Immunology. 13 (751705): 751705-751705 - 2022-01-27 13(751705),
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
View ORCID ProfileGemma Moncunill, Ruth Aguilar, Marta Ribes, Natalia Ortega, Rocío Rubio, Gemma Salmeron, María José Molina, Marta Vidal, Diana Barrios, Robert A. Mitchell, Alfons Jimenez, Cristina Castellana, Pablo Hernández-Luis, Pau Rodó, Susana Méndez, Anna Llupià, Laura Puyol, Natalia Rodrigo Melero, Carlo Carolis, Alfredo Mayor, Luis Izquierdo, Pilar Varela, Antoni Trilla, Anna Vilella, Sonia Barroso, Ana Angulo, Pablo Engel, Marta Tortajada, Alberto L. García-Basteiro, Carlota Dobaño
Ebiomedicine. 75 - 2022-01-01 75()
Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins
Benjamin Lang, Jae-Seong Yang, Mireia Garriga-Canut, Silvia Speroni, Moritz Aschern, Maria Gili, Tobias Hoffmann, Gian Gaetano Tartaglia, Sebastian P Maurer
Nucleic Acids Research. 49 (12): 6702-6721 - 2021-07-09 49(12)
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
Carlota Dobaño, Rebeca Santano, Alfons Jiménez, Marta Vidal ,Jordi Chi , Natalia Rodrigo Melero, Matija Popovic, Rubén López-Aladid, Laia Fernández-Barat, Marta Tortajada, Francisco ,Carmona-Torre ,Gabriel Reina, Antoni Torres, Alfredo Mayor, Carlo Carolis, Alberto L. García-Basteiro ,Ruth Aguilar, Gemma Moncunill, Luis Izquierdo
Transl Res. 23260-74 - 2021-06-01 232()
A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported
David Ruano-Gallego,Miriam García-Villadangos,Mercedes Moreno-Paz,Javier Gómez-Elvira,Marina Postigo,María Simón-Sacristán,Hugh T. Reyburn,Carlo Carolis,Natalia Rodrigo,Yaiza B. Codeseira,Paloma Rueda,Sonia Zúñiga,Luis Enjuanes,Victor Parro
Microbial Biotechnology. 14 (3): 1228-1236 - 2021-05-01 14(3)

INSTITUTE

CRG - Centre de Regulació Genòmica

Parc de Recerca Biomèdica de Barcelona (PRBB)
Dr. Aiguader, 88

08003 Barcelona http://www.crg.eu/

DOMAINS RIS3CAT

  • Education and knowledge generation system
  • Industrial system
  • Socio-sanitary system

CATEGORIES

  • TECHNOLOGICAL EQUIPMENT
    • Other specializated laboratories
    • Proteomics

RATES AND ACCESS

Availability Level: High
Access Procedures:

Open – Check conditions.

CERCA - Ginys